Alex Crowe
- Physiology top 5%
- Molecular Biology
- Pharmacology top 5%
- Cellular and Molecular Neuroscience top 10%
- Neurology top 5%
- Co-authors
- Virginia M.‐Y. LeeJohn Q. TrojanowskiDennis W. DicksonAmos B. SmithCarlo BallatoreS. -H. YenKurt R. BrundenÁine L. Plant
- Topics
- Alzheimer's disease research and treatments (17 papers)Cholinesterase and Neurodegenerative Diseases (8 papers)Computational Drug Discovery Methods (4 papers)
- Cited by
- PhysiologyNeurologyPharmacology
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Alex Crowe
29 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 109
- Physiology 771
- Molecular Biology 508
- Pharmacology 284
- Cellular and Molecular Neuroscience 248
- Neurology 200
Countries citing papers authored by Alex Crowe
This map shows the geographic impact of Alex Crowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Crowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Crowe more than expected).
Fields of papers citing papers by Alex Crowe
This network shows the impact of papers produced by Alex Crowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Crowe. The network helps show where Alex Crowe may publish in the future.
Co-authorship network of co-authors of Alex Crowe
This figure shows the co-authorship network connecting the top 25 collaborators of Alex Crowe. A scholar is included among the top collaborators of Alex Crowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Crowe. Alex Crowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 14 | |
| 4 | 56 | |
| 5 | 60 | |
| 6 | 116 | |
| 7 | 38 | |
| 8 | 23 | |
| 9 | 82 | |
| 10 | 155 | |
| 11 | 87 | |
| 12 | 10 | |
| 13 | 41 | |
| 14 | 35 | |
| 15 | 2 | |
| 16 | 36 | |
| 17 | 63 | |
| 18 | 66 | |
| 19 | The N terminal region of human tau is present in Alzheimer's disease protein A68 and is incorporated into paired helical filaments. | 24 |
| 20 | 14 |
About Alex Crowe
Alex Crowe is a scholar working on Physiology, Neurology and Pharmacology, having authored 29 papers that have together received 1.4k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (17 papers), Cholinesterase and Neurodegenerative Diseases (8 papers) and Computational Drug Discovery Methods (4 papers). The work is most often cited by research in Physiology (771 citations), Neurology (200 citations) and Pharmacology (284 citations). Alex Crowe has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Virginia M.‐Y. Lee, John Q. Trojanowski, Dennis W. Dickson, Amos B. Smith, Carlo Ballatore, S. -H. Yen, Kurt R. Brunden, Áine L. Plant, Allison R. Kermode and Michael J. James. Their work appears in journals such as Journal of Biological Chemistry, Journal of Neuroscience and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.